We are happy to announce that we're celebrating 30 years! →

REQUEST FREE CONSULTATION
Published on:

By

hospital-834150_640Two Alzheimer’s drugs Leqembi and Kisunla were approved by the FDA to treat mild dementia or a pre-Alzheimer’s condition called mild cognitive impairment. Data had suggested that Leqembi could slow cognitive decline in Alzheimer’s patients by five months over a period of 18 months for patients who had only mild symptoms. Two thousand volunteers had agreed to test Leqembi in clinical studies.  However, it turns out these drugs may also increase the risk for brain bleeds and swelling in patients with certain genetic profiles—and patients may not have been given enough information. If you suffered brain bleeds or swelling during a clinical trial for Leqembi or Kisunla, you may be able to recover compensation.

Call Moll Law Group About Your Claim

Investigation shows that drug manufacturers Eisai and Eli Lilly may not have disclosed to certain people in their clinical trials that they were more vulnerable to brain bleeding or swelling. The clinical trial for Leqembi had 274 volunteers without the manufacturer alerting them that they were at especially high risk to develop brain injuries. Eli Lilly also failed to tell volunteers in its Kisunla studies of increased risks, and dozens of those volunteers suffered severe brain bleeding.

Patients in the clinical studies should have received adequate information about the increased risks they faced due to their genetic profiles. Generally, patients must give informed consent before they take a medication for the study; patients cannot give informed consent if they have not been told the risks of taking a medication. In both of the trials, the volunteers were required to sign consent forms that let them know people with certain profiles faced greater risk of brain injuries while taking the drugs and that while participants would be tested for those risks, they wouldn’t be told the results.

Continue reading →

Published on:

By

boy-6536864_640-e1744671951359On February 20, 2025, Super 73 recalled its Z Miami SE and Z Adventure Core electric bikes because it was found that the e-bike’s disc brake calipers have a retaining pin that can disengage from the caliper assembly. This can lead to a failure of the brakes and serious accidents and injuries. The recalled e-bikes are models from 2024. If you were injured in an accident involving 2024 Z Miami SE (900-00288, 900-00309 and 900-00313) or Z Adventure Core (900-00308) e-bikes, call the seasoned Chicago-based lawyers of Moll Law Group to determine your legal options. Billions have been recovered in product liability lawsuits with which we’ve been involved across the country.

Call the Chicago-Based Lawyers of Moll Law Group

Around 1400 units were affected by the recall. The impacted Z Miami SE e-bikes come in three colors: black with a black seat (“Bandit”), gray with a camel seat (“Palladium”), and orange with a black seat (“Astro Orange”). However, the impacted Z Adventure Core e-bikes come only in black and brown frame that is marketed as “Sandstorm.” If you have one of these bikes, you should look at the receipt you received when purchasing it to determine whether you have an affected model or color, which will be listed there.

The manufacturer Super 73 has gotten 21 reports of loose retaining pins and brake failure, and this has resulted in a minor injury. The e-bikes were sold in the manufacturer’s store in Irvine, as well as the manufacturer’s website other bike stores around the country between April 2024-September 2024. The cost of the bike, which is made in Taiwan, was $2300-$2500.

Continue reading →

Published on:

By

acne-1606765_640-e1744671619257Recently, the Food and Drug Administration issued a recall for possible benzene contamination in popular brands like La Roche-Posay, Proactiv, Walgreens and other acne products. Through third party-testing, the agency had tested 95 acne products that contained benzoyl peroxide for contamination, and found certain products should be recalled, but only at the retail level. The companies whose products were found to contain contamination voluntarily agreed to be part of the recall.

Call Chicago-based Moll Law Group About Your Claim

All the products in the recall are skincare products that contain benzoyl peroxide, an ingredient found in many over-the-counter products used to treat acne. The recall products are:

  • Lot number MYX46W of La Roche-Posay Effaclar Duo Dual Action Acne Treatment, which expires April 2025
  • Lot number 23 09328 of Walgreens Acne Control Cleanser, which expires September 2025
  • Lot numbers of V3305A and V3304A of Proactiv Emergency Blemish Relief Cream Benzoyl Peroxide 5%, which expires October 2025
  • Lot V4204A of Proactiv Skin Smoothing Exfoliator, which expires July 2025
  • Lot 2430600 of SLMD Benzoyl Peroxide Acne Lotion, which expires March 2025
  • Lot 49707430 of Walgreens Tinted Acne Treatment Cream, which expires March 2026.

Moreover, the manufacturer of Zapzyt Acne Treatment Gel voluntarily recalled its acne product based on its own testing that found a higher benzene level.

Continue reading →

Published on:

By

enduro-8548196_640-e1744671023884The Triumph TF250-X Off-Road Motorcycle, which is imported by Triumph Motorcycles America, has been recalled because it has a flaw that can result in injuries. Specifically, the plastic switch cube on the right side of the motorcycle may crack if it comes into contact with brake fluid; this in turn may result in a short circuit that unexpectedly starts the motorcycle. Riders or other people can be injured. The recall was issued on February 20, 2025.

Call the Chicago-Based Trial Lawyers of Moll Law Group

The products at issue are the black 2024 and 2025 Triumph TF250-X Closed Competition Motorcycle, which have vehicle identification numbers (VIN) between BP6028 and CC7868 specified on the left side of the motorcycle’s steering head. Around 690 units are affected, and you can see whether your VIN is included in the recall by going to https://www.triumphmotorcycles.com/owners/recalls.

These off-road motorcycles, made in Thailand, were sold from July 2023-December 2024. The cost was roughly $9500.

Continue reading →

Published on:

By

lawn-mower-384589_640-e1744669896483Recently, after a three-week trial, jurors in a state court awarded $2 billion in punitive damages to a plaintiff who had sued Bayer-owned Monsanto and alleged that the company’s Roundup herbicide had caused his cancer. Around $65 million in compensatory damages was awarded for non-Hodgkin lymphoma that the plaintiff argued he developed after using the weed killer. This is one of the largest verdicts in a Roundup case—Bayer plans to appeal. If you developed cancer because you were exposed to Roundup, you should call the seasoned product liability lawyers of Moll Law Group. Billions have been recovered in cases with which we’ve been involved around the nation.

Consult Moll Law Group About Your Claim

The plaintiff had used the herbicide in his own yard. Doctors diagnosed him with non-Hodgkin lymphoma in 2020. His case was brought with allegations that the active ingredient in the weedkiller was glyphosate, which caused his cancer. He argued that Monsanto failed to warn him that the product was dangerous. His case is one of more than 60,000 similar cases. Bayer has paid around $10 billion to settle claims that the herbicide causes cancer and has set aside $5.9 billion to address legal proceedings.

Bayer had acquired Roundup when it took over the agrochemical company Monsanto in 2018. The German pharmaceutical and biotechnology group acquired Roundup as part of its $63 billion takeover of U.S. agrochemical company Monsanto in 2018. In response to this latest verdict, the company said it disagreed with the verdict, and claimed it was in conflict with an overwhelming amount of scientific evidence to the contrary, as well as the consensus of numerous regulatory bodies around the globe. It plans to appeal. Bayer has also said that it may stop selling Roundup if lawmakers don’t strengthen legal protections against product liability litigation.

Continue reading →

Published on:

By

intravenous-141551_640-e1741659930879Recently, ICU Medical, Inc. voluntarily recalled certain lots of potassium chloride injection bags with overwrap labels. This came after a customer complaint was received that Potassium Chloride Inj. Bags that had overlap labels of 20 mEq, which incorrectly identify the bag as Potassium Chloride Inj. 10mEq. This mislabeling has the potential to cause harm. If you were harmed due to improperly labeled potassium chloride, you should call the seasoned Chicago-based lawyers of Moll La Group to determine your legal options. Billions have been recovered in cases with which we’ve been involved around the country.

Contact Moll Law Group About a Potassium Chloride Claim

The manufacturer has recalled certain batches of Potassium Chloride due to the possibility of mislabeling on product overwraps so that certain units are identified as 10 mEq instead of 20 mEq. When that incorrect overwrap is in place, the correct 20 mEq label fixed to the bag can’t be seen easily. This can cause serious problems.

If a health care provider calculates the patient’s dose of the medication using the 10mEq label, the patient will get an intravenous overdose of potassium chloride. This can lead to problems like death from cardiac arrest, dysrhythmias, hypotension, confusion, and neuromuscular dysfunction such as ascending paralysis, vertigo, mental confusion and vertigo. Various groups are at real risk for adverse or even fatal consequences; these groups include premature infants, patients who have had cardiac arrhythmia, patients who have had chronic renal insufficiency or acute renal failure, and patients on chronic  parenteral nutrition. However, it should be noted that there haven’t been reports of adverse events due to the mislabeling thus far.

Continue reading →

Published on:

By

According to the Food and Drug Administration (FDA), on December 9, 20240food-2202344_1280-e17416582561004, the Chicago-based company Riverside Natural Foods voluntarily recalled over 2.4 million cases of the popular MadeGood granola bars because of the potential presence of metal in the bars. These bars have been sold across the country. If you were harmed by unsafe food call the seasoned Chicago-based attorneys of Moll Law Group to find out your legal options. Billions have been recovered in cases with which we’ve been involved.

Call the Lawyers of Moll Law Group About Your Granola Bar Claim

The Class II recall applies to several different kinds of MadeGood granola bars, which have been touted as healthier allerge-free and organic snack alternatives. The affected bars were made between January-November 2024 and were distributed across the country and internationally.

Class II recalls are instituted when the recalled products can cause temporary or medically reversible adverse health consequences. The manufacturer claims that the recall has been initiated out of an abundance of caution.

Continue reading →

Published on:

By

chocolate-smoothie-1058191_640-e1741658058922A multistate outbreak of listeria monocytogenes has impacted frozen supplement shakes made by Prairie Farms. As of February 21, 2025, 38 people have been infected by the outbreak across 21 states. On February 22, 2025, Lyons Magnus LLC recalled affected Prairie Farms supplement shakes and people were advised not to sell, eat or serve them. The Centers for Disease Control (CDC), along with officials have been gathering data to figure out the causes of this outbreak. If you were harmed by supplemental shakes contaminated with listeria monocytogenes, you should call the knowledgeable Chicago-based food safety lawyers of Moll Law Group. Billions have been recovered in cases with which we’ve been involved.

Call Seasoned Moll Law Group About Your Supplement Shake Claim

As of February 21, 2025, 38 people infected with the outbreak strain of Listeria monocytogenes have been reported from 21 states. Sick people’s samples were collected on dates ranging from August 17, 2018, to January 23, 2025. Of 38 people with information available, 37 have been hospitalized. Twelve deaths have been reported from California, Illinois, Indiana, Michigan, Minnesota, North Carolina, New York, Tennessee, Texas, and Washington. Most people in this outbreak reported living in long-term care facilities or were hospitalized prior to becoming sick.

Not everyone reports when they’ve been affected by Listeria (and not everyone gets tested for it). Accordingly, it’s possible there are more sick people than were originally counted.

Continue reading →

Published on:

By

medical-5835701_640-e1741657233713Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to manage type 2 diabetes and obesity and have the potential to help other medical problems like depression, addiction, and Alzheimer’s. Unfortunately, it also appears that one of the drugs’ potential side effects is a rare kind of vision loss, non-arteritic anterior ischemic optic neuropathy (NAION). Around 12% of people around the country has taken semaglutide drugs and around 6% of Americans are currently taking them. No direct causal link has been established, but as popularity of these drugs grow, it’s important to be aware of this possible risk. If you suffered NAION while on Ozempic, Wegovy or another GLP-1 drug, you should call the seasoned Chicago-based dangerous pharmaceuticals lawyers of Moll Law Group.

Call Moll Law Group About Your Semaglutide Claim

Only a small group of patients taking semaglutide have experienced vision issues. A JAMA study, one of several studies, looked at 9 patients that had vision trouble while taking semaglutide.

NAION is a non-inflammatory disease in which the blood supply to the optic nerve is harmed and the patient suffers a sudden partial vision loss that’s permanent. The study was initiated because a patient experienced a painless vision loss while on the drug but had the issue resolve favorably when semaglutide was stopped; when he went back on, he had the same problem with the other eye. The researcher looked into whether other neuro-ophthalmologists had seen this in their patients and found nine cases that are featured in his study. Seven out of nine of the patients, all of them in their 50s and 60s, had typical presentations of NAION, which usually affects only one eye at once, but some had unusual symptoms. Researchers are trying to figure out whether being on semaglutide actually causes NAION and other vision loss.

Continue reading →

Published on:

By

donuts-2969490_1280-e1739548302659In February, the Food and Drug Administration (FDA) announced that it is recalling 60 baked products due to potential listeria contamination concerns. Around 2 million baked goods manufactured by FGF Brands, which is a pastry wholesaler, were affected. These baked goods, which were made before December 13, 2024, include French crullers, fritters, cinnamon sticks, filled and flavored doughnuts. If you suffered listeria as a result of a baked good made by FGF brands, you should contact Moll Law Group to determine your legal options. Billions have been recovered in product liability lawsuits with which we’ve been involved.

Call Moll Law Group About Your Baked Goods Claim

The recall was first issued in January but was upgraded to a Class II recall; these are recalls where use of the recalled product could cause temporary adverse medical consequences or where the probability of serious negative consequences is remote. Next steps for consumers were not automatically provided by the FDA.

If you suffered listeria poisoning or listeriosis, you may have a basis to sue for damages. Listeriosis is a foodborne bacterial infection that’s commonly caused by the bacterium listeria monocytogenes. As the third leading cause of death from foodborne sickness, listeria affects around 1600 Americans each year, according to the Centers for Disease Control and Prevention (CDC) and can be especially serious when suffered by older adults, those with weakened immune systems, and pregnant women. It’s estimated that about 260 people die each year from infections and symptoms include muscle aches, headache, fever, stiff neck, loss of balance, convulsions, diarrhea, and confusion. Those who are pregnant may suffer miscarriage, stillbirth, premature delivery, or their newborns may suffer life-threatening infections. In the worst case, listeria can result in death.

Continue reading →

Contact Information
180 N Stetson Ave 35th Floor
Chicago, IL 60601
T 312.462.1700F 312.756.0045E info@molllawgroup.com
We represent people nationwide including, but not limited to, those in the following localities: Atlanta, Baltimore, Boston, Chicago, Dallas–Fort Worth, Denver, Detroit, Houston, Los Angeles, Miami, New York City, Philadelphia, Phoenix, San Bernardino-Riverside, San Diego, San Francisco, Seattle, St. Louis, Tampa–St. Petersburg, and Washington, D.C.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Please do not include any confidential or sensitive information in a contact form, text message, or voicemail. The contact form sends information by non-encrypted email, which is not secure. Submitting a contact form, sending a text message, making a phone call, or leaving a voicemail does not create an attorney-client relationship.

Copyright © 2025, Moll Law Group
JUSTIA Law Firm Blog Design